About Neha

Neha represents emerging and high-growth companies through all stages of the corporate life cycle. She advises clients on various corporate transactions, including private financings, public offerings and mergers & acquisitions. She also provides day-to-day corporate governance counsel to public and private companies.

View full bio

Experience

Enavate Sciences Co-Leads Sudo Biosciences’ $116 Million Series B

Enavate Sciences Co-Leads Sudo Biosciences’ $116 Million Series B

December 20, 2023

Cooley advised Enavate Sciences, a top investment firm, as the co-lead investor in the $116 million Series B financing round of Sudo Biosciences, a biopharmaceutical company committed to designing and developing best-in-class precision tyrosine kinase 2 inhibitors. Partners Marc Recht and Brandon Fenn led the Cooley team advising Enavate Sciences.

Related contacts

Marc Recht
Partner, Boston
Brandon W. Fenn
Partner, New York
Alex Abelson
Associate, New York
Neha Mehta
Associate, New York

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences

Admissions and credentials

New York